Hengrui Medicine has received approval for clinical trials for its SHR-A2009 drug and Adebelimumab injection. The company's subsidiaries, Suzhou Shengdiya Biopharmaceutical and Shanghai Shengdi Biopharmaceutical, will commence clinical trials soon. In unrelated news, the People's Bank of China will conduct a 500 billion yuan reverse repurchase operation, and DeepSeek has reportedly become the top global service for API calls. AI
IMPACT DeepSeek's rise to global API call leadership suggests increasing adoption and demand for advanced AI models.
RANK_REASON The cluster contains news about drug clinical trial approvals, which falls under research. [lever_c_demoted from research: ic=1 ai=0.7]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
